Joel Adam Cohen - Publications

Affiliations: 
2009 University of California, Berkeley, Berkeley, CA, United States 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Thomas DG, Smith JN, Thrall BD, Baer DR, Jolley H, Munusamy P, Kodali V, Demokritou P, Cohen J, Teeguarden JG. ISD3: a particokinetic model for predicting the combined effects of particle sedimentation, diffusion and dissolution on cellular dosimetry for in vitro systems. Particle and Fibre Toxicology. 15: 6. PMID 29368623 DOI: 10.1186/S12989-018-0243-7  0.381
2011 Cohen JL, Schubert S, Wich PR, Cui L, Cohen JA, Mynar JL, Fréchet JMJ. Acid-degradable cationic dextran particles for the delivery of siRNA therapeutics Bioconjugate Chemistry. 22: 1056-1065. PMID 21539393 DOI: 10.1021/Bc100542R  0.763
2011 Cui L, Cohen JA, Broaders KE, Beaudette TT, Fréchet JMJ. Mannosylated dextran nanoparticles: A pH-sensitive system engineered for immunomodulation through mannose targeting Bioconjugate Chemistry. 22: 949-957. PMID 21476603 DOI: 10.1021/Bc100596W  0.753
2010 Cohen JA, Beaudette TT, Cohen JL, Broaders KE, Bachelder EM, Fréchet JMJ. Acetal-modified dextran microparticles with controlled degradation kinetics and surface functionality for gene delivery in phagocytic and non-phagocytic cells Advanced Materials. 22: 3593-3597. PMID 20518040 DOI: 10.1002/Adma.201000307  0.755
2009 Liu Y, Ibricevic A, Cohen JA, Cohen JL, Gunsten SP, Fréchet JM, Walter MJ, Welch MJ, Brody SL. Impact of hydrogel nanoparticle size and functionalization on in vivo behavior for lung imaging and therapeutics. Molecular Pharmaceutics. 6: 1891-902. PMID 19852512 DOI: 10.1021/Mp900215P  0.606
2009 Beaudette TT, Cohen JA, Bachelder EM, Broaders KE, Cohen JL, Engleman EG, Fréchet JMJ. Chemoselective ligation in the functionalization of polysaccharide-based particles Journal of the American Chemical Society. 131: 10360-10361. PMID 19591467 DOI: 10.1021/Ja903984S  0.747
2009 Beaudette TT, Bachelder EM, Cohen JA, Obermeyer AC, Broaders KE, Fréchet JM, Kang ES, Mende I, Tseng WW, Davidson MG, Engleman EG. In vivo studies on the effect of co-encapsulation of CpG DNA and antigen in acid-degradable microparticle vaccines. Molecular Pharmaceutics. 6: 1160-9. PMID 19415922 DOI: 10.1021/Mp900038E  0.729
2009 Broaders KE, Cohen JA, Beaudette TT, Bachelder EM, Fréchet JM. Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy. Proceedings of the National Academy of Sciences of the United States of America. 106: 5497-502. PMID 19321415 DOI: 10.1073/Pnas.0901592106  0.708
2009 Cohen JA, Beaudette TT, Tseng WW, Bachelder EM, Mende I, Engleman EG, Fréchet JM. T-cell activation by antigen-loaded pH-sensitive hydrogel particles in vivo: the effect of particle size. Bioconjugate Chemistry. 20: 111-9. PMID 19102625 DOI: 10.1021/Bc800338N  0.797
2008 Cohen JL, Almutairi A, Cohen JA, Bernstein M, Brody SL, Schuster DP, Fréchet JM. Enhanced cell penetration of acid-degradable particles functionalized with cell-penetrating peptides. Bioconjugate Chemistry. 19: 876-81. PMID 18318462 DOI: 10.1021/Bc700414J  0.676
2007 Mynar JL, Goodwin AP, Cohen JA, Ma Y, Fleming GR, Fréchet JM. Two-photon degradable supramolecular assemblies of linear-dendritic copolymers. Chemical Communications (Cambridge, England). 2081-2. PMID 17713085 DOI: 10.1039/B701681F  0.709
2006 Hayes ME, Drummond DC, Hong K, Zheng WW, Khorosheva VA, Cohen JA, Noble IV CO, Park JW, Marks JD, Benz CC, Kirpotin DB. Increased target specificity of anti-HER2 genospheres by modification of surface charge and degree of PEGylation Molecular Pharmaceutics. 3: 726-736. PMID 17140260 DOI: 10.1021/Mp060040V  0.307
Show low-probability matches.